#sustained virologic response

The risk was lower in people who had achieved a sustained virological response compared with those who had not.

If your previous treatment for hep C resulted in failure, can you undergo treatment again? This question, and others, answered here.

Premature discontinuation of hepatitis C treatment did not diminish the likelihood of sustained virological response.

Sustained response to direct-acting antivirals prolonged survival by a year and a half.

Once you’ve officially rid yourself of hepatitis C, how certain can you be that the virus is gone for good?

Treatment for hep C is easier than ever before. In clinical trials, roughly 95 percent of those who took the newest meds were cured.

Ridding the body of hep C reduces central fatigue, which is weakness originating in the central nervous system.

Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus in a recent...

Preliminary data from a trial of daclatasvir, asunaprevir and BMS-791325 showed hepatitis C cure rates around 90 percent.

Improves cure rates of hepatitis C and does not raise major treatment risks in those coinfected with HIV.

Much attention is focused on the effort to achieve a cure for hepatitis C. But what actually happens after the virus is finally gone?

People with cirrhosis who are cured of hepatitis C have significantly lowered risk of liver decompensation, liver cancer and death.

Adding Incivek to pegylated interferon and ribavirin doubles the cure rate and cuts in half the treatment time for acute hepatitis C among HIV...

Promising Phase III results from a trial of Gilead Sciences’s hepatitis C antiviral sofosbuvir open the door for regulatory filing this...

With numerous obstacles preventing widespread treatment of the U.S. hepatitis C population, how can the health care system successfully...

For people with hepatitis C and chronic liver disease, retreatment with interferon monotherapy is unlikely to improve their condition and may...